Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
“The FDA said the reason for the recall is that the ‘product failed to meet dissolution acceptance criteria in the stability studies at the 6th month.'”
Cardiology August 5th 2025
Journal of the American College of Cardiology (JACC)
First randomized evidence supporting feasibility of maintaining cardiac stability with carvedilol alone after systematic withdrawal of other heart failure medications in selected patients.
Cardiology June 3rd 2025
In this comprehensive analysis of 2,853 TTS patients, beta-blocker therapy demonstrated a significant 29% reduction in mortality risk during follow-up, particularly within the first year after discharge.
Cardiology February 10th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS